Who owns Pacira BioSciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PCRX from SEC Form 13F filings across 254 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 254 institutions disclosed 43.8M shares of Pacira BioSciences, Inc. worth $1.12B — about 110.9% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
254
13F holders
$1.12B
value, 2026 filers
110.9%
of shares outstanding (43.8M sh)
41
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of PCRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.7M | $170.1M | 0.0% | 17% | -0.4% |
| 2 | Doma Perpetual Capital Management LLC | 2.8M | $70.5M | 16.4% | 7% | 0.0% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.4M | $61.0M | 0.0% | 6.1% | -3.8% |
| 4 | DIMENSIONAL FUND ADVISORS LP | 2.1M | $53.4M | 0.0% | 5.3% | +2.1% |
| 5 | STATE STREET CORP | 2.1M | $52.3M | 0.0% | 5.2% | +7.3% |
| 6 | D. E. Shaw & Co., Inc. | 2.0M | $49.5M | 0.0% | 4.9% | -1.6% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 1.7M | $44.0M | 0.1% | 4.4% | -5.0% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | $42.9M | 0.0% | 4.3% | -5.2% |
| 9 | GOLDMAN SACHS GROUP INC | 1.5M | $38.7M | 0.0% | 3.9% | -2.7% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.2M | $29.4M | 0.0% | 2.9% | +1.3% |
| 11 | MORGAN STANLEY | 1.1M | $29.0M | 0.0% | 2.9% | -17.8% |
| 12 | AMERICAN CENTURY COMPANIES INC | 1.0M | $25.8M | 0.0% | 2.6% | +21.6% |
| 13 | UBS Group AG | 920,217 | $23.3M | 0.0% | 2.3% | +63.7% |
| 14 | Impax Asset Management Group plc | 750,027 | $19.0M | 0.1% | 1.9% | 0.0% |
| 15 | TWO SIGMA INVESTMENTS, LP | 724,604 | $18.4M | 0.0% | 1.8% | +37.5% |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 690,786 | $17.5M | 0.0% | 1.8% | -5.6% |
| 17 | GAGNON SECURITIES LLC | 608,617 | $15.4M | 3.0% | 1.5% | -1.4% |
| 18 | LSV ASSET MANAGEMENT | 608,376 | $15.4M | 0.0% | 1.5% | +17.7% |
| 19 | WELLINGTON MANAGEMENT GROUP LLP | 563,458 | $14.3M | 0.0% | 1.4% | +17.8% |
| 20 | NORTHERN TRUST CORP | 526,782 | $13.4M | 0.0% | 1.3% | +1.4% |
| 21 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 411,373 | $10.4M | 0.2% | 1% | 0.0% |
| 22 | DEUTSCHE BANK AG\ | 391,101 | $9.9M | 0.0% | 1% | -0.1% |
| 23 | Jefferies Financial Group Inc. | 370,092 | $9.4M | 0.1% | 0.9% | +88.5% |
| 24 | Hillsdale Investment Management Inc. | 362,700 | $9.2M | 0.2% | 0.9% | +9.5% |
| 25 | Gagnon Advisors, LLC | 352,637 | $8.9M | 5.7% | 0.9% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.